Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 192
8
Diseases
68
Unique genes
0.298
Avg. similarity score
Cerebral small vessel disease
Most-connected disease (6 links)
Disease
Searched: Brain small vessel disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Brain small vessel disease
Cerebral small vessel disease
Congenital porencephaly
Posttraumatic porencephalic cyst of brain
Vascular leukoencephalopathy
Cerebral palsy
Intracerebral hemorrhage
Ectopic thyroid tissue
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Cerebral small vessel disease | 6 | 6 | 2 |
| Congenital porencephaly | 6 | 6 | 2 |
| Posttraumatic porencephalic cyst of brain | 6 | 6 | 2 |
| Vascular leukoencephalopathy | 6 | 6 | 2 |
| Brain small vessel disease | 5 | 5 | 5 |
| Cerebral palsy | 5 | 5 | 46 |
| Intracerebral hemorrhage | 5 | 5 | 21 |
| Ectopic thyroid tissue | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| COL4A1 | 7 / 8 | Brain small vessel disease, Cerebral palsy, Cerebral small vessel disease, Congenital porencephaly and 3 more |
| COL4A2 | 7 / 8 | Brain small vessel disease, Cerebral palsy, Cerebral small vessel disease, Congenital porencephaly and 3 more |
| FBXO31 | 2 / 8 | Cerebral palsy, Ectopic thyroid tissue |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Crosslinking of collagen fibrils | Reactome | 3 / 18 | 29.4× | 1.33e-4 | 2.75e-3 ✓ sig. |
| GABAergic synapse | KEGG | 5 / 89 | 9.9× | 1.44e-4 | 2.93e-3 ✓ sig. |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | Reactome | 3 / 20 | 26.5× | 1.85e-4 | 3.57e-3 ✓ sig. |
| Mitotic Prometaphase | Reactome | 5 / 113 | 7.8× | 4.39e-4 | 7.11e-3 ✓ sig. |
| EML4 and NUDC in mitotic spindle formation | Reactome | 5 / 117 | 7.5× | 5.15e-4 | 8.04e-3 ✓ sig. |
| Sealing of the nuclear envelope (NE) by ESCRT-III | Reactome | 3 / 31 | 17.1× | 6.97e-4 | 1.02e-2 ✓ sig. |
| Resolution of Sister Chromatid Cohesion | Reactome | 5 / 126 | 7.0× | 7.21e-4 | 1.05e-2 ✓ sig. |
| Signaling by PDGF | Reactome | 3 / 33 | 16.1× | 8.39e-4 | 1.17e-2 ✓ sig. |
| Focal adhesion | KEGG | 6 / 203 | 5.2× | 9.92e-4 | 1.33e-2 ✓ sig. |
| RHO GTPases Activate Formins | Reactome | 5 / 140 | 6.3× | 1.16e-3 | 1.51e-2 ✓ sig. |
| Gap junction | KEGG | 4 / 89 | 7.9× | 1.60e-3 | 1.93e-2 ✓ sig. |
| Eicosanoids | Reactome | 2 / 12 | 29.4× | 2.01e-3 | 2.29e-2 ✓ sig. |
| Hypertrophic cardiomyopathy | KEGG | 4 / 99 | 7.1× | 2.36e-3 | 2.57e-2 ✓ sig. |
| Fatty acids | Reactome | 2 / 15 | 23.5× | 3.16e-3 | 3.18e-2 ✓ sig. |
| Extracellular matrix organization | Reactome | 2 / 15 | 23.5× | 3.16e-3 | 3.18e-2 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| cardiac myofibril assembly | GO:0055003 | 3 / 13 | 63.4× | 1.28e-5 | 6.38e-4 ✓ sig. |
| menaquinone catabolic process | GO:0042361 | 2 / 5 | 110× | 1.30e-4 | 3.69e-3 ✓ sig. |
| regulation of viral entry into host cell | GO:0046596 | 2 / 6 | 91.6× | 1.94e-4 | 4.94e-3 ✓ sig. |
| phylloquinone catabolic process | GO:0042376 | 2 / 6 | 91.6× | 1.94e-4 | 4.94e-3 ✓ sig. |
| microtubule-based process | GO:0007017 | 3 / 46 | 17.9× | 6.25e-4 | 1.12e-2 ✓ sig. |
| cerebral cortex cell migration | GO:0021795 | 2 / 11 | 50.0× | 7.03e-4 | 1.21e-2 ✓ sig. |
| telomere maintenance via recombination | GO:0000722 | 2 / 11 | 50.0× | 7.03e-4 | 1.21e-2 ✓ sig. |
| icosanoid metabolic process | GO:0006690 | 2 / 11 | 50.0× | 7.03e-4 | 1.21e-2 ✓ sig. |
| collagen-activated tyrosine kinase receptor signaling pathway | GO:0038063 | 2 / 12 | 45.8× | 8.41e-4 | 1.36e-2 ✓ sig. |
| positive regulation of miRNA transcription | GO:1902895 | 3 / 56 | 14.7× | 1.11e-3 | 1.62e-2 ✓ sig. |
| regulation of DNA damage checkpoint | GO:2000001 | 2 / 15 | 36.6× | 1.33e-3 | 1.81e-2 ✓ sig. |
| locomotory exploration behavior | GO:0035641 | 2 / 16 | 34.4× | 1.51e-3 | 1.95e-2 ✓ sig. |
| layer formation in cerebral cortex | GO:0021819 | 2 / 18 | 30.5× | 1.92e-3 | 2.23e-2 ✓ sig. |
| leukotriene metabolic process | GO:0006691 | 2 / 18 | 30.5× | 1.92e-3 | 2.23e-2 ✓ sig. |
| positive regulation of peptidyl-serine phosphorylation | GO:0033138 | 2 / 20 | 27.5× | 2.38e-3 | 2.54e-2 ✓ sig. |